Chronic Myelogenous Leukemia Panel - Disclosures as of 7/6/2010
View NCCN Management Team Disclosures | View NCCN Guidelines Staff Disclosures | View NCCN ORP Staff Disclosures| Panel Member | Clinical Research Support | Advisory Boards, Speakers Bureau, Expert Witness, or Consultant | Patent, Equity, or Royalty | Other | Date Completed |
|---|---|---|---|---|---|
Camille N. Abboud, MD |
None |
Genzyme Corporation; |
None |
None |
4/5/2013 |
Ellin Berman, MD |
None |
None |
None |
None |
1/22/2013 |
Hossein Borghaei, DO, MS |
None |
Amgen Inc.; |
None |
None |
7/2/2012 |
Daniel J. DeAngelo, MD, PhD |
None |
Bristol-Myers Squibb Company; |
None |
None |
3/16/2012 |
Marcel P. Devetten, MD |
None |
Bristol-Myers Squibb Company; |
None |
None |
12/30/2009 |
Steven Devine, MD |
Genzyme Corporation |
Novartis Pharmaceuticals Corporation; |
None |
None |
5/14/2013 |
Lauren Gallagher, RPh, PhD |
None |
None |
None |
None |
6/5/2012 |
Jason Gotlib, MD, MS |
None |
Novartis Pharmaceuticals Corporation |
None |
None |
11/8/2012 |
Kristina M. Gregory, RN, MSN, OCN |
None |
None |
None |
None |
10/23/2012 |
Madan Jagasia, MD |
None |
None |
None |
None |
4/1/2012 |
Joan S. McClure, MS |
None |
None |
None |
None |
7/23/2012 |
Joseph O. Moore, MD |
None |
Amgen Inc.; |
None |
None |
8/24/2012 |
Susan O'Brien, MD |
None |
None |
None |
None |
8/31/2012 |
Javier Pinilla-Ibarz, MD, PhD |
None |
Novartis Pharmaceuticals Corporation; |
None |
None |
4/20/2012 |
Jerald P. Radich, MD |
None |
Bristol-Myers Squibb Company; |
None |
None |
1/29/2013 |
Neil P. Shah, MD, PhD |
None |
None |
None |
None |
5/2/2011 |
Paul J. Shami, MD |
None |
Novartis Pharmaceuticals Corporation |
JSK Therapeutics Inc. |
None |
1/28/2013 |
B. Douglas Smith, MD |
None |
Bristol-Myers Squibb Company; |
None |
None |
1/19/2013 |
David S. Snyder, MD |
None |
Bristol-Myers Squibb Company; |
None |
None |
2/27/2013 |
Hema Sundar, PhD |
None |
None |
None |
None |
2/25/2013 |
Moshe Talpaz, MD |
None |
ARIAD Pharmaceuticals, Inc.; |
None |
None |
10/6/2009 |
Meir Wetzler, MD |
None |
Bristol-Myers Squibb Company; |
None |
None |
8/7/2012 |
Furhan Yunus, MD, FACP |
None |
None |
None |
None |
4/2/2012 |
About NCCN| NCCN Member Institutions| Patient Resources| NCCN Foundation| Privacy Policy| Legal Notices| Contact Us
275 Commerce Drive, Suite 300, Fort Washington, PA 19034 • 215.690.0300 • Fax: 215.690.0260
Copyright © 2012 National Comprehensive Cancer Network, All Rights Reserved